KILL Extending overall survival is less important than quality of life and disease stability for the majority of physicians treating patients with advanced lung cancer following first-line chemotherapy

Boehringer Ingelheim requests that their press release NewsItemId: 20150925005203 issued September 25, 2015entitled "Extending overall survival is less important than quality of life and disease stability for the majority of physicians treating patients with advanced lung cancer following first line-chemotherapy" be killed.

The release was issued prematurely by Boehringer Ingelheim.

A replacement release will not be issued.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150925005203/en/

Contacts:

Media Contact
Boehringer Ingelheim
Corporate Communications
Media PR
Dr Reinhard Malin
Phone: [phone]
Fax: [phone]
Email: [e-mail]